| Jennifer C Hsia, MD | |
|
4365 Pheasant Ridge Dr Ne Ste 106, Blaine, MN 55449-4544 | |
| (888) 938-3838 | |
| (888) 919-1083 |
| Full Name | Jennifer C Hsia |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 19 Years |
| Location | 4365 Pheasant Ridge Dr Ne Ste 106, Blaine, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174633184 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 55650 (Minnesota) | Secondary |
| 207Y00000X | Otolaryngology | 76417 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ear Institutes Llc | 4880928761 | 10 |
News Archive
There's hope for a better life for people who've lost an arm or leg, thanks to new research funded by the National Science Foundation and the Department of Defense.
Scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) - sometimes called "pink eye" - a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone. Their report describing an innovative new "molecular wipe" that sweeps up viruses responsible for EKC appears in ACS's Journal of Medicinal Chemistry.
The reason Children's Medical Research Institute (CMRI) exists is to find ways to treat or prevent childhood disease. Our research programs are focussed on the areas of cancer cell growth, nerve cell signalling, embryology and gene therapy. These four programs have a shared aim of translating novel findings into new treatments for the benefit of families everywhere.
Endomagnetics, the company co-founded in the United Kingdom by a University of Houston researcher to develop products to improve the standard of breast cancer care, has been named one of two winners of an inaugural Nanomedicine Award in the European Union.
Combination immunotherapy as second or third line treatment extends overall survival to at least 15 months in patients with pleural malignant mesothelioma, according to late-breaking results from the MAPS2 trial presented today at the ESMO 2017 Congress in Madrid.
› Verified 2 days ago
| Entity Name | University Of Minnesota Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477598118 PECOS PAC ID: 9830001189 Enrollment ID: O20031104000532 |
News Archive
There's hope for a better life for people who've lost an arm or leg, thanks to new research funded by the National Science Foundation and the Department of Defense.
Scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) - sometimes called "pink eye" - a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone. Their report describing an innovative new "molecular wipe" that sweeps up viruses responsible for EKC appears in ACS's Journal of Medicinal Chemistry.
The reason Children's Medical Research Institute (CMRI) exists is to find ways to treat or prevent childhood disease. Our research programs are focussed on the areas of cancer cell growth, nerve cell signalling, embryology and gene therapy. These four programs have a shared aim of translating novel findings into new treatments for the benefit of families everywhere.
Endomagnetics, the company co-founded in the United Kingdom by a University of Houston researcher to develop products to improve the standard of breast cancer care, has been named one of two winners of an inaugural Nanomedicine Award in the European Union.
Combination immunotherapy as second or third line treatment extends overall survival to at least 15 months in patients with pleural malignant mesothelioma, according to late-breaking results from the MAPS2 trial presented today at the ESMO 2017 Congress in Madrid.
› Verified 2 days ago
| Entity Name | Fairview Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013994359 PECOS PAC ID: 1951213057 Enrollment ID: O20031105000461 |
News Archive
There's hope for a better life for people who've lost an arm or leg, thanks to new research funded by the National Science Foundation and the Department of Defense.
Scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) - sometimes called "pink eye" - a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone. Their report describing an innovative new "molecular wipe" that sweeps up viruses responsible for EKC appears in ACS's Journal of Medicinal Chemistry.
The reason Children's Medical Research Institute (CMRI) exists is to find ways to treat or prevent childhood disease. Our research programs are focussed on the areas of cancer cell growth, nerve cell signalling, embryology and gene therapy. These four programs have a shared aim of translating novel findings into new treatments for the benefit of families everywhere.
Endomagnetics, the company co-founded in the United Kingdom by a University of Houston researcher to develop products to improve the standard of breast cancer care, has been named one of two winners of an inaugural Nanomedicine Award in the European Union.
Combination immunotherapy as second or third line treatment extends overall survival to at least 15 months in patients with pleural malignant mesothelioma, according to late-breaking results from the MAPS2 trial presented today at the ESMO 2017 Congress in Madrid.
› Verified 2 days ago
| Entity Name | Ear Institutes Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881168441 PECOS PAC ID: 4880928761 Enrollment ID: O20190626002606 |
News Archive
There's hope for a better life for people who've lost an arm or leg, thanks to new research funded by the National Science Foundation and the Department of Defense.
Scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) - sometimes called "pink eye" - a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone. Their report describing an innovative new "molecular wipe" that sweeps up viruses responsible for EKC appears in ACS's Journal of Medicinal Chemistry.
The reason Children's Medical Research Institute (CMRI) exists is to find ways to treat or prevent childhood disease. Our research programs are focussed on the areas of cancer cell growth, nerve cell signalling, embryology and gene therapy. These four programs have a shared aim of translating novel findings into new treatments for the benefit of families everywhere.
Endomagnetics, the company co-founded in the United Kingdom by a University of Houston researcher to develop products to improve the standard of breast cancer care, has been named one of two winners of an inaugural Nanomedicine Award in the European Union.
Combination immunotherapy as second or third line treatment extends overall survival to at least 15 months in patients with pleural malignant mesothelioma, according to late-breaking results from the MAPS2 trial presented today at the ESMO 2017 Congress in Madrid.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer C Hsia, MD 10001 W Innovation Dr Ste 200, Milwaukee, WI 53226-4851 Ph: (888) 938-3838 | Jennifer C Hsia, MD 4365 Pheasant Ridge Dr Ne Ste 106, Blaine, MN 55449-4544 Ph: (888) 938-3838 |
News Archive
There's hope for a better life for people who've lost an arm or leg, thanks to new research funded by the National Science Foundation and the Department of Defense.
Scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) - sometimes called "pink eye" - a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone. Their report describing an innovative new "molecular wipe" that sweeps up viruses responsible for EKC appears in ACS's Journal of Medicinal Chemistry.
The reason Children's Medical Research Institute (CMRI) exists is to find ways to treat or prevent childhood disease. Our research programs are focussed on the areas of cancer cell growth, nerve cell signalling, embryology and gene therapy. These four programs have a shared aim of translating novel findings into new treatments for the benefit of families everywhere.
Endomagnetics, the company co-founded in the United Kingdom by a University of Houston researcher to develop products to improve the standard of breast cancer care, has been named one of two winners of an inaugural Nanomedicine Award in the European Union.
Combination immunotherapy as second or third line treatment extends overall survival to at least 15 months in patients with pleural malignant mesothelioma, according to late-breaking results from the MAPS2 trial presented today at the ESMO 2017 Congress in Madrid.
› Verified 2 days ago
Yasmina Ahmed, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4365 Pheasant Ridge Dr Ne Ste 106, Blaine, MN 55449 Phone: 888-938-3838 Fax: 888-919-1083 |